We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Today’s business environment demands a seamless and continual transition of digital experience to conduct business and engage various stakeholders in the same way we conduct the rest of our lives outside work. The experience expectation is consistent across devices of choice from phones to tablets to laptops. That’s why West partners with the world’s top pharmaceutical, biotech, device and diagnostic companies to embrace technology that supports the patients they serve with online resources and tools to better manage their health. In turn, we’re looking to support our customers with digital tools to help speed the research and development process of bringing life-saving medicines to patients that need them.
Companies seeking to bring an injectable medicine to market are required to complete an immense amount of research on the medicine itself, but they must also study the containment or device options to help ensure that medicine is delivered safely to the patient. The regulatory hurdles associated with combination therapies that include both the medicine, together with a device, represent a host of additional regulatory requirements.
To support customers, West’s Knowledge Center offers an online repository of scientific and regulatory support content that can help customers get the information they need quickly to manage this regulatory process. West also offers commonly requested, detailed product information, including specifications and drawings, on our entire portfolio of elastomer packaging components, pre-filled syringe solutions and wearable devices. Recently, we added the ability to purchase some of these same products through our online store. All of these services are available across a range of digital platforms, so that customers can easily access this information 24 hours a day, regardless of the device they use.
This is just one of the ways West is working to Simplify the Journey™ for our customers, by making it easier for our customers to do what we consider to be some of life’s most important work—developing innovative new medicines to address unmet medical needs. To learn more watch the above video or visit the West Knowledge center.
#SimplifytheJourney #WestByYourSide
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
I’ve worked at West for 28 years. I lead our Venture Group, Global Labs, and Data Science Team; I’ve spent most of my career in R&D. There’s an expectation from our customers that West will lead the way in developing new products. Ones that are going to be better for patients, easier to use and more cost efficient for the health system. That expectation drives a lot of the R&D work we do.
Scott Young
VP, R&D, Labs, Venture and Ext Collaboration Engineering
As advancements in pharmaceutical technology increase in the use of automated injection systems for health care treatment, traditional glass vials, syringes and cartridges must withstand higher automated delivery forces and pressures. The fragile nature and dimensional variability in wall thickness of glass components may lead to breakage, which presents challenges to automatic administration systems.
At its 8th Annual Scholarship & Awards Banquet, the Young Men and Women in Charge (YMWIC) Foundation presented West Pharmaceutical Services, Inc. with the organization’s first-ever Impact Award.
Biosimilar development and approvals have been accelerated over the last several years. The rapid uptake in this category is due in large part to clarity on regulatory pathways that demonstrate interchangeability with the reference product and key patent expiry over the next decade. By 2025 injectable biosimilars are projected to comprise almost 50% of the accessible biologics market<sup>1</sup>. West recently conducted a survey of biosimilar companies to better understand their top needs for packaging and support services during drug development.
West’s subject matter experts are out and about this spring with speaking engagements and booths booked at a variety of conferences and trade shows.